Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Journal of Pain and Symptom Management
|
May 18, 2010
Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated
Alfredo H Navigante, Monica A Castro, Leandro C Cerchietti
Blood
|
October 18, 2008
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo
Leandro C Cerchietti, Shao Ning Yang, Rita Shaknovich, et al.
Cancer Research
|
May 3, 2008
Sequential transcription factor targeting for diffuse large B-cell lymphomas
Leandro C Cerchietti, Jose M Polo, Gustavo F Da Silva, et al.
Nature Medicine
|
December 8, 2009
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
Leandro C Cerchietti, Eloisi C Lopes, Shao Ning Yang, et al.
Nature Medicine
|
April 3, 2024
Author Correction: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
Leandro C Cerchietti, Eloisi C Lopes, Shao Ning Yang, et al.
The Journal of Clinical Investigation
|
November 3, 2010
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy
Leandro C Cerchietti, Katerina Hatzi, Eloisi Caldas-Lopes, et al.
Cancer Cell
|
April 14, 2010
A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo
Leandro C Cerchietti, Alexandru F Ghetu, Xiao Zhu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Journal of Pain and Symptom Management
|
May 18, 2010
Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated
Alfredo H Navigante, Monica A Castro, Leandro C Cerchietti
Blood
|
October 18, 2008
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo
Leandro C Cerchietti, Shao Ning Yang, Rita Shaknovich, et al.
Cancer Research
|
May 3, 2008
Sequential transcription factor targeting for diffuse large B-cell lymphomas
Leandro C Cerchietti, Jose M Polo, Gustavo F Da Silva, et al.
Nature Medicine
|
December 8, 2009
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
Leandro C Cerchietti, Eloisi C Lopes, Shao Ning Yang, et al.
Nature Medicine
|
April 3, 2024
Author Correction: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
Leandro C Cerchietti, Eloisi C Lopes, Shao Ning Yang, et al.
The Journal of Clinical Investigation
|
November 3, 2010
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy
Leandro C Cerchietti, Katerina Hatzi, Eloisi Caldas-Lopes, et al.
Cancer Cell
|
April 14, 2010
A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo
Leandro C Cerchietti, Alexandru F Ghetu, Xiao Zhu, et al.
Page
of 1